A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Reads0
Chats0
TLDR
In this article, a 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity, and increasing scores on the scale were strongly associated with multiple domains of functional impairment.Abstract:
Background Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. Methods A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. Results A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. Conclusion The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.read more
Citations
More filters
Journal ArticleDOI
Psychiatric symptom dimensions are associated with dissociable shifts in metacognition but not task performance
TL;DR: This study bridges a gap between an emerging neuroscience of decision making and an understanding of metacognitive alterations in psychopathology, indicating a specific and pervasive link between metacognition and mental health.
Journal ArticleDOI
Adolescents' Perceived Socio-Emotional Impact of COVID-19 and Implications for Mental Health: Results From a U.S.-Based Mixed-Methods Study.
TL;DR: Adolescents perceived various changes in their relationships with family and friends during COVID-19 and these perceived social and emotional changes were associated with elevated depressive symptoms, anxiety symptoms, and loneliness in April 2020, controlling for mental health problems before the pandemic.
Journal ArticleDOI
Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics
Philip Awadalla,Catherine Boileau,Yves Payette,Youssef Idaghdour,Jean Philippe Goulet,Bartha Maria Knoppers,P. Hamet,Claude Laberge +7 more
TL;DR: The CaG study is one of the few population-based cohorts in the world where blood is stored not only for DNA and protein based science but also for gene expression analyses, opening the door for multiple systems genomics approaches that identify genetic and environmental factors associated with disease-related quantitative traits.
Journal ArticleDOI
Mental distress during the COVID-19 pandemic among US adults without a pre-existing mental health condition: Findings from American trend panel survey.
Calliope Holingue,Calliope Holingue,Elena Badillo-Goicoechea,Kira E. Riehm,Cindy B. Veldhuis,Johannes Thrul,Renee M. Johnson,M. Daniele Fallin,Frauke Kreuter,Elizabeth A. Stuart,Luther G. Kalb +10 more
TL;DR: Assessment of the frequency and risk and protective factors of psychological distress, during the beginning of the COVID-19 pandemic, in this group of individuals found that searching online or using social media to post about coronavirus, reporting that the outbreak caused major changes to personal life, and perception that the virus was a threat to the US economy, the individual's personal health or finances contributed to distress.
Journal ArticleDOI
Disorder-specific versus transdiagnostic and clinician-guided versus self-guided treatment for major depressive disorder and comorbid anxiety disorders: A randomized controlled trial.
Nickolai Titov,Blake F. Dear,Lauren G. Staples,Matthew D. Terides,Eyal Karin,Joanne Sheehan,Luke Johnston,Milena Gandy,Vincent J. Fogliati,Bethany M. Wootton,Peter M. McEvoy +10 more
TL;DR: No marked or consistent differences were observed across the four conditions, highlighting the efficacy of different forms of CBT at treating MDD and comorbid disorders.
References
More filters
Journal ArticleDOI
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
John E. Ware,Cathy D. Sherbourne +1 more
TL;DR: A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Journal ArticleDOI
The PHQ-9: validity of a brief depression severity measure.
TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Journal ArticleDOI
An inventory for measuring clinical anxiety: psychometric properties.
TL;DR: Un nouvel inventaire auto-administre destine a mesurer l'anxiete pathologique, le «Beck Anxiety Cheklist» (BAI) est decrit, evalue et compare au «Hamilton Anxiety Rating Scale» (test avec lequel des correlations moderees sont trouvees).
Journal ArticleDOI
The validity of the Hospital Anxiety and Depression Scale: An updated literature review
TL;DR: HADS was found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population.